Top 5 Stocks to Buy Now
→ Elon’s message for America (From Stansberry Research) (Ad)tc pixel Free AZN Stock Alerts

Astrazeneca (AZN) Short Interest Ratio & Short Volume

Astrazeneca logo
$185.61 +2.59 (+1.41%)
Closing price 06/25/2026 03:59 PM Eastern
Extended Trading
$185.00 -0.61 (-0.33%)
As of 06/25/2026 07:09 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Astrazeneca Short Interest Overview

As of June 15, 2026, Astrazeneca (AZN) had a short interest of 1.33 million shares sold short, representing 0.09% of the public float. This marks a -22.84% decrease in short interest since the prior report. The short interest ratio (days to cover) is 0.6, meaning it would take 0.6 days of the average trading volume of 1.88 million shares to cover all short positions.

Current Short Interest
1,326,546 shares
Previous Short Interest
1,719,165 shares
Change Vs. Previous Month
-22.84%
Dollar Volume Sold Short
$235.28 million
Short Interest Ratio
0.6 Days to Cover
Last Record Date
June 15, 2026
Outstanding Shares
1,550,910,000 shares
Short Percent of Float
0.09%
Today's Trading Volume
1,826,205 shares
Average Trading Volume
1,883,475 shares
Today's Volume Vs. Average
97%
Short Selling Astrazeneca?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Astrazeneca and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

AZN Short Interest Over Time

AZN Days to Cover Over Time

AZN Percentage of Float Shorted Over Time

Astrazeneca Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/15/20261,326,546 shares $235.28 million -22.8%0.1%0.63 $177.36
5/29/20261,719,165 shares $318.91 million -20.5%0.1%0.96 $185.50
5/15/20262,162,492 shares $392.75 million +18.1%0.1%1.2 $181.62
4/30/20261,830,898 shares $343.49 million +5.2%0.1%0.83 $187.61
4/15/20261,740,147 shares $350.02 million +8.0%0.1%0.92 $201.14
3/31/20261,611,139 shares $317.72 million -18.4%0.1%0.86 $197.20
2/27/20262,380,486 shares $496.21 million -4.3%0.2%1.21 $208.45
2/13/20262,487,804 shares $511.37 million +1,536.8%0.2%0.81 $205.55
1/30/20263,881,346 shares $360.07 million -68.4%0.3%0.33 $92.77
1/15/202612,267,466 shares $1.15 billion +12.1%0.4%1.79 $93.99
12/31/202510,940,007 shares $1.01 billion +31.5%0.4%2.84 $91.93
12/15/20258,318,927 shares $761.68 million -9.5%0.3%1.38 $91.56
11/28/20259,192,060 shares $851.18 million -7.8%0.3%1.71 $92.60
11/14/20259,968,173 shares $888.16 million +4.4%0.3%2.06 $89.10
10/31/20259,546,642 shares $786.64 million +36.5%0.3%2.41 $82.40
10/15/20257,000,000 shares $593.81 million +28.2%0.2%1.4 $84.83
9/30/20255,460,000 shares $418.89 million -29.5%N/A1.1 $76.72
9/15/20257,740,000 shares $604.11 million -0.4%N/A1.8 $78.05
8/31/20257,770,000 shares $620.82 million +25.5%0.3%1.8 $79.90
8/15/20256,190,000 shares $490.06 million +16.1%N/A1.4 $79.17
7/31/20255,330,000 shares $389.57 million -14.7%0.2%1.1 $73.09
7/15/20256,250,000 shares $439.50 million -8.2%N/A1.4 $70.32
6/30/20256,810,000 shares $475.88 million -8.6%0.2%1.3 $69.88
6/15/20257,450,000 shares $554.43 million +7.7%0.2%1.4 $74.42
5/31/20256,920,000 shares $503.91 million -5.7%0.2%1.2 $72.82
5/15/20257,340,000 shares $498.83 million +52.3%0.2%1.2 $67.96
4/30/20254,820,000 shares $346.03 million -23.9%N/A0.8 $71.79
4/15/20256,330,000 shares $429.62 million -40.3%0.2%1.1 $67.87
3/31/202510,600,000 shares $779.10 million -30.5%0.3%1.8 $73.50
3/15/202515,240,000 shares $1.18 billion -10.2%0.5%2.8 $77.60
2/28/202516,970,000 shares $1.29 billion +9.8%0.5%3 $76.21
2/15/202515,460,000 shares $1.14 billion -8.7%0.5%2.9 $73.58
1/31/202516,940,000 shares $1.20 billion +12.2%N/A2.8 $70.76
1/15/202515,100,000 shares $991.77 million +19.0%N/A2.5 $65.68
12/31/202412,690,000 shares $831.45 million +26.1%N/A2.3 $65.52
12/15/202410,060,000 shares $669.79 million +36.0%N/A1.8 $66.58
11/30/20247,400,000 shares $500.39 million -8.3%N/A1.4 $67.62
11/15/20248,070,000 shares $510.27 million +74.3%N/A1.5 $63.23
10/31/20244,630,000 shares $329.42 million +14.9%N/A0.9 $71.15
10/15/20244,030,000 shares $313.74 million -25.2%N/A0.9 $77.85
Gold Will Hit $4,900 (Ad)

JPMorgan now sees gold hitting $4,900, and central banks are buying at a record 710 tonnes per quarter. Trump's tariffs are accelerating the move, sending prices sharply higher in 2026. One $15 fund is converting gold's rally into monthly income of up to $1,152 - no trading, no options, no physical gold required.tc pixel

Click here to lock in your first payout before the next surge
9/30/20245,390,000 shares $419.93 million -16.4%N/A1.2 $77.91
9/15/20246,450,000 shares $504.84 million -27.2%N/A1.5 $78.27
8/31/20248,860,000 shares $776.31 million +4.1%N/A2.1 $87.62
8/15/20248,510,000 shares $722.50 million +49.0%N/A2.1 $84.90
7/31/20245,710,000 shares $451.95 million -1.6%N/A1.4 $79.15
7/15/20245,800,000 shares $453.10 million -9.5%N/A1.4 $78.12
6/30/20246,410,000 shares $499.92 million -19.2%N/A1.4 $77.99
6/15/20247,930,000 shares $631.15 million +18.9%N/A1.6 $79.59
5/31/20246,670,000 shares $520.39 million -13.0%N/A1.3 $78.02
5/15/20247,670,000 shares $590.36 million -10.1%N/A1.4 $76.97
4/30/20248,530,000 shares $647.26 million -0.6%N/A1.3 $75.88
4/15/20248,580,000 shares $589.70 million +12.0%N/A1.4 $68.73
3/31/20247,660,000 shares $518.97 million -26.9%N/A1.2 $67.75
3/15/202410,480,000 shares $694.93 million +13.2%N/A1.7 $66.31
2/29/20249,260,000 shares $594.12 million +3.8%N/A1.5 $64.16
2/15/20248,920,000 shares $560.53 million +117.6%N/A1.4 $62.84
1/31/20244,100,000 shares $273.22 million -29.4%N/A0.7 $66.64
1/15/20245,810,000 shares $403.33 million -6.6%N/A1.1 $69.42
12/31/20236,220,000 shares $418.92 million +8.9%N/A1.1 $67.35
12/15/20235,710,000 shares $370.01 million -27.7%N/A1 $64.80
11/30/20237,900,000 shares $510.26 million -2.5%N/A1.4 $64.59
11/15/20238,100,000 shares $511.35 million -10.1%N/A1.6 $63.13
10/31/20239,010,000 shares $569.70 million +53.8%N/A1.8 $63.23
10/15/20235,860,000 shares $394.55 million -3.9%N/A1.2 $67.33
9/30/20236,100,000 shares $413.09 million -27.2%N/A1.3 $67.72
9/15/20238,380,000 shares $572.10 million +14.3%N/A1.6 $68.27
8/31/20237,330,000 shares $497.12 million +49.0%N/A1.4 $67.82
8/15/20234,920,000 shares $341.99 million -18.7%N/A0.9 $69.51
7/31/20236,050,000 shares $433.79 million -5.2%N/A1.2 $71.70
7/15/20236,380,000 shares $429.88 million -15.9%N/A1.3 $67.38
6/30/20237,590,000 shares $543.22 million +27.1%N/A1.7 $71.57
6/15/20235,970,000 shares $445.48 million +22.3%N/A1.4 $74.62
5/31/20234,880,000 shares $356.63 million +4.5%N/A1.2 $73.08
5/15/20234,670,000 shares $350.20 million -19.6%N/A1.2 $74.99
4/30/20235,810,000 shares $425.41 million +44.5%N/A1.3 $73.22
4/15/20234,020,000 shares $296.92 million +6.1%N/A0.8 $73.86
3/31/20233,790,000 shares $263.06 million +21.5%N/A0.8 $69.41
3/15/20233,120,000 shares $201.49 million -10.1%N/A0.6 $64.58
2/28/20233,470,000 shares $226.17 million +28.5%N/A0.7 $65.18
2/15/20232,700,000 shares $188.16 million +8.0%N/A0.6 $69.69
1/31/20232,500,000 shares $163.43 million -50.3%N/A0.5 $65.37
1/15/20235,030,000 shares $357.53 million +18.9%N/A1 $71.08
12/30/20224,230,000 shares $286.79 million -14.2%N/A0.8 $67.80
12/15/20224,930,000 shares $343.82 million +13.3%N/A0.9 $69.74
11/30/20224,350,000 shares $295.67 million -6.7%N/A0.7 $67.97
11/15/20224,660,000 shares $298.01 million -14.3%N/A0.7 $63.95
10/31/20225,440,000 shares $319.93 million -5.6%N/A0.8 $58.81
10/15/20225,760,000 shares $316.63 million +20.8%N/A0.9 $54.97
9/30/20224,770,000 shares $261.59 million -25.7%N/A0.7 $54.84
9/15/20226,420,000 shares $373.26 million -29.4%N/A1 $58.14
Trump's gold order: the announcement they won't put on the front page (Ad)

On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no debate, no vote, one executive order. Gold tripled within three years and climbed 20x over the following decade. Trump holds that same executive authority today, and his advisors are openly saying a reversal is on the table. There are two ways this plays out - both move gold in the same direction. A free briefing breaks down exactly what Nixon did, why Trump is positioned to act, and how to move your 401k into gold before any announcement - tax free.tc pixel

Request the free guide in 30 seconds and get positioned now
8/31/20229,090,000 shares $567.03 million -12.5%N/A1.4 $62.38
8/15/202210,390,000 shares $694.16 million -23.8%N/A1.7 $66.81
7/31/202213,640,000 shares $903.38 million -0.2%N/A2.1 $66.23
7/15/202213,670,000 shares $920.81 million +4.2%N/A2 $67.36
6/30/202213,120,000 shares $866.84 million -11.1%N/A1.9 $66.07
6/15/202214,760,000 shares $894.01 million +36.2%N/A2.1 $60.57
5/31/202210,840,000 shares $720.64 million -34.0%N/A1.6 $66.48
5/15/202216,420,000 shares $1.04 billion +39.7%N/A2.1 $63.14
4/30/202211,750,000 shares $780.20 million +8.6%N/A1.5 $66.40
4/15/202210,820,000 shares $747.12 million +39.4%N/A1.3 $69.05
3/31/20227,760,000 shares $514.80 million -1.7%N/A1 $66.34
3/15/20227,890,000 shares $484.21 million -12.6%N/A1.1 $61.37
2/28/20229,030,000 shares $549.75 million +9.7%N/A1.3 $60.88
2/15/20228,230,000 shares $496.27 million +54.7%N/A1.3 $60.30
1/31/20225,320,000 shares $309.68 million -12.8%N/A1 $58.21
1/15/20226,100,000 shares $358.99 million -1.3%N/A1.3 $58.85
12/31/20216,180,000 shares $359.99 million -1.6%N/A1.4 $58.25
12/15/20216,280,000 shares $349.92 million -16.8%N/A1.3 $55.72
11/30/20217,550,000 shares $413.97 million +8.5%N/A1.4 $54.83
11/15/20216,960,000 shares $416.07 million +2.7%N/A1.3 $59.78
10/29/20216,780,000 shares $422.94 million -5.0%N/A1.3 $62.38
10/15/20217,140,000 shares $429.97 million -0.1%N/A1.2 $60.22
9/30/20217,150,000 shares $429.43 million +9.5%N/A0.7 $60.06
9/15/20216,530,000 shares $368.62 million +1.9%N/A0.7 $56.45
8/31/20216,410,000 shares $373.57 million +14.3%N/A0.6 $58.28
8/13/20215,610,000 shares $328.07 million -25.5%N/A0.5 $58.48
7/30/20217,530,000 shares $431.02 million -94.7%N/A0.7 $57.24
7/15/2021142,900,000 shares $8.14 billion +4.4%N/A14 $56.96
6/30/2021136,940,000 shares $8.20 billion +1.4%5.2%17.4 $59.90

AZN Short Interest - Frequently Asked Questions

Short interest is the volume of Astrazeneca shares that have been sold short but have not yet been covered or closed out. As of June 15th, investors have sold 1,326,546 shares of AZN short. 0.09% of Astrazeneca's shares are currently sold short. Learn More on Astrazeneca's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AZN shares currently have a short interest ratio of 0.6. Learn More on Astrazeneca's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.09% of Astrazeneca's floating shares are currently sold short.

Astrazeneca saw a decrease in short interest during the month of June. As of June 15th, there was short interest totaling 1,326,546 shares, a decrease of 22.8% from the previous total of 1,719,165 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

0.09% of Astrazeneca's shares are currently sold short. Here is how the short interest of companies compare to Astrazeneca: Amgen Inc. (2.28%), Biogen Inc. (3.52%), Moderna, Inc. (16.58%), Novavax, Inc. (27.88%), AbbVie Inc. (1.33%), Bristol Myers Squibb Company (1.94%), Johnson & Johnson (1.11%), Eli Lilly and Company (1.03%), Merck & Co., Inc. (1.23%), Pfizer Inc. (2.86%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($77.25 billion), Invesco QQQ ($51.70 billion), iShares Russell 2000 ETF ($25.75 billion), Sandisk Corporation ($23.00 billion), Western Digital Corporation ($17.29 billion), Nebius Group N.V. ($13.25 billion), SPDR S&P Biotech ETF ($10.78 billion), KLA Corporation ($10.45 billion), Salesforce Inc. ($9.71 billion), and VanEck Semiconductor ETF ($9.01 billion). View all of the most shorted stocks.

Short selling AZN is an investing strategy that aims to generate trading profit from Astrazeneca as its price is falling. AZN shares are trading up $2.59 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Astrazeneca occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of AZN, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AZN, twice per month. The most recent reporting period available is June, 15 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like AZN:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NYSE:AZN) was last updated on 6/25/2026 by MarketBeat.com Staff.
From Our Partners
BlackRock is hoarding it. JPMorgan is hoarding it. Do you own it?
BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...
Awesomely, LLC | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel
Elon Is Quietly Doubling Down on This Bizarre Asset
Yahoo Finance reports this technology 'May Unlock $400 Trillion' - and Bloomberg calls it 'unavoidable.' Elon ...
Brownstone Research | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Do NOT Buy SpaceX – Do This Instead
SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...
Stansberry Research | Sponsoredtc pixel
Rickards Predicts: Trump to buy tiny $2 stock?
Jim Rickards believes the Trump administration is about to take a direct stake in a $2 stock sitting on the la...
Paradigm Press | Sponsoredtc pixel
Bill Gates said this would never work. Then he wrote a $100M check.
Bill Gates spent a decade insisting this energy source couldn't supply more than 5% of global power. Then he t...
Behind the Markets | Sponsoredtc pixel